THE RANGE OF FUNCTIONAL MUTATIONS AND THEIR CONTRIBUTION TO THE FORMATION OF BLAST CELLS AND THE DEVELOPMENT OF LEUKEMIA (LITERATURE REVIEW)
Keywords:
hemoblastosis, mutations, allows, requiresAbstract
The main important factor in the structure of hemoblastosis and the pathogenesis of leukemia is the occurrence of mutations in these genes. Thus, the detection of molecular genetic changes in the tumor clone, as well as the comprehensive assessment of the main signaling pathways in tumor cells, not only allows understanding tumor biology, but also provides new information in patients with acute leukemia requires additional scientific research to help develop diagnostic and treatment criteria.
References
Alieva M.D., V.G. Polyakova, G.L. Mentkevich, S.A. Mayakova. – M.: Pediatric oncology. National leadership; ed. Publishing group RONTS, 2012. - 681 p.
Baranova, O.Yu. Possibilities of modern therapy of acute non-lymphoblastic leukemias in adults / O.Yu. Baranova, M.A. Volkova // Russian medical journal. - 2001. - V. 9, No. 22. - S. 999
Bogdanov, A.N. A case of acute lymphoblastic leukemia with t(9; 22) translocation and several additional rearrangements / A.N. Bogdanov, O.V. Sarzhevsky, S.N. Kolyubaeva // Hematology and transfusiology. - 2008. - No. 3. - S. 35-38.
Demidova, I.A. Using molecular biological methods to determine genetic disorders in myeloid leukemia and monitor minimal residual disease / I.A. Demidova // Oncohematology. - 2007. - No. 4. - S. 17-26.
Zaridze, D.G. Epidemiology of leukemia in children / D.G. Zaridze // Archive of Pathology. –1997. - T. 59, No. 5. - S. 65-70.
Zarubina K.I., 2021.
Omarova, K.O. Epidemiological features of acute myeloid leukemia in Kazakhstan [Electronic resource] / K.O. Omarova, Zh.B. Sauranbaeva // Ecology and health of children. - 2000. - Astana. - Access mode: http://pediatrics.med.kz/conf/2000/ec108.html
Rumyantseva A.G. - M .: A practical guide to childhood diseases. Hematology/oncology of childhood; ed. Medpraktika, 2002. - P.468.
Savchenko V.G., Parovichnikova E.N. Afanasiev B.V. "National clinical guidelines for the diagnosis and treatment of adult acute myeloid leukemia" Gematol. and transfusiol. Russia 2014 v56 №1
Saliev D. Dynamics of the spread of leukemia in Karakalpakstan and in five regions of Uzbekistan over the last two five-year periods (2001-2005 and 2006-2010) / D. Saliev, K.K. Saliev // Bulletin of Hematology. - 2014. - T. 10, No. 2. - S. 133-136.
Usenova A.A., - Bishkek 2016.- Article 8-9.
Khairoeva, N.A. Medico-statistical monitoring of acute leukemia in children of the Republic of Kazakhstan / N.A. Khairoeva: Author. diss. ... cand. honey. Sciences. - Almaty, 2010. - S. 9-10.
Khodzhieva G.B., M.K. Rakhmatov, J.M. Khasanov, K.Z. Urakov, 2018.
Chissova V.I., S.L. Daryalova. - M.: Publishing house "News", Selected lectures on clinical oncology: ed. 2000. - 256 p.
Fazoil I. A., Novichkova G. A., Kuznetsova S. A. "A method for the differential diagnosis of acute leukemia using a cell biochip" Russia 2017.12.18.
Arber DA et al., 2016.
Chan, GCF Current Status of Acute Lymphoblastic Leukaemia in Children / GCF Chan, CH Pui // J. Peadiatr. - 2003. - No. 8. - R. 170-183.
Comeaux EQ, 2017.
David, A. Rates and Trends of Pediatric Acute Lymphoblastic Leukemia - United States, 2001–2014 / A. David, S. Jane Henley, Lori A. Pollack, // Morbidity and Mortality Weekly Report. - 2017. - Vol. 66. - R. 950-954.
Descher, B. Acute myeloid leukemia: epidemiology and etiology / B. Descher, M. Lubbert // Cancer. - 2006. - No. 107. - R. 2099-2107.
Evangelisti C., A. Cappellini, M. Oliveira, 2021; R. Fragoso, J.T.Barata, A. Bertaina, 2019; F. Locatelli, 2020.
Francisco, G. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies / G. Francisco, PR Menezes, J. Eluf-Neto et al. // Int. J. Cancer. - 2011. - Vol. 129, No. 4. - R. 920-930.
Groves FD, BTWatkins, DJRoberts, TCTucker, T. Shen, TJFlood, 2019).
Gusstafsson, G. Sex and other prognostic factors in acute lymphoblastic leukemia in childhood / G. Gusstafsson, A. Kreuger // The American J. of pediatric Hematology/oncology. - 1983. - Vol. 5. - R. 243-250.
Harrison C.J., 2019; H.Inaba, 2019.
Hellström A., D. Ley, I. Hansen-Pupp, B. Hallberg, 2018.
Holmfeldt L., Wei L., Diaz-Flores E., Walsh M., Zhang J., Ding L., et al. 2019; Hsiao MH, Yu AL, Yeargin J., Ku D., Haas M. 2020.
Jerchel IS, AQHoogkamer, IMAriës, EMSteeghs, 2020; JMBoer, NJBesselink, A.Boeree, 2021.
Swerdlow, S., Campo, E., Harris, N. L, Jaffe, ES, Pileri, SA, Stein, H., ... & Vardiman, JW (2008). WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues 4th Ed.
Tian, X. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies / X. Tian, D. Shundong, S. Jing // Published online. - 2016. - Vol. 6, No. 3. - R. 1152.
Yeoh, EJ Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling / EJ Yeoh, ME Ross, SA Syurtleff et al. // Cancerctl. - 2002. - Vol. 1. - R. 133-143.
